No Data
No Data
Express News | The USA plans to initiate "double anti" investigations against China regarding erythritol, with relevant product prices having already rebounded this year.
Baolingbao Biology Investing Up to 622 Million Yuan in US Project
Express News | Baolingbao Biology: Plans to increase capital to its wholly-owned subsidiary by no more than 0.622 billion yuan to establish a functional sugar project in the USA.
Express News | Baolingbao Biology and Fengli Jingqiu have reached a strategic cooperation.
Baolingbao biology (002286.SZ) third quarter equity distribution: a dividend of 0.35 yuan for every 10 shares.
baolingbao (002286.SZ) announced that the company's equity distribution plan for the third quarter of 2024 is as follows: to distribute the company's...
baolingbao (002286.SZ): products with pharmaceutical excipient qualifications such as erythritol and maltodextrin have been expanded for application in the pharmaceutical field.
On November 4, baolingbao (002286.SZ) stated on the investor interaction platform that the company has currently expanded the application of erythritol and maltodextrin, both of which have pharmaceutical excipient qualifications, in the field of medicine.